Please use this identifier to cite or link to this item:

TitleFluconazole versus Voriconazole: Candida glabrata biofilms response to different azoles
Author(s)Rodrigues, Célia Fortuna
Gonçalves, Bruna
Rodrigues, E.
Silva, Sónia Carina
Azeredo, Joana
Henriques, Mariana
KeywordsCandida glabrata
Resistance mechanisms
Issue date9-Oct-2015
PublisherJohn Wiley and Sons
CitationRodrigues, Célia F.; Gonçalves, B.; Rodrigues, E.; Silva, Sónia Carina; Azeredo, Joana; Henriques, Mariana, Fluconazole vs Voriconazole: Candida glabratas biofilms response to different azoles. 7th Trends in Medical Mycology. Vol. Mycoses 58(Suppl. 4), Lisbon, Portugal, 9-12 Oct, 78-78, 2015.
Abstract(s)Candida glabrata is the second most prevalent yeast in fungal infections, especially in immunocompromised and/or hospitalized patients. The azole resistance within this species is very well-known and results in a low therapeutic response of C. glabrata infections, particularly when associated with biofilms. Objective - To understand the different efficacies of two azoles against C. glabrata biofilms: - fluconazole (Flu), a long time used drug - voriconazole (Vcz), a latest drug used only in hospitals.
Publisher version
AccessOpen access
Appears in Collections:CEB - Resumos em Livros de Atas / Abstracts in Proceedings

Files in This Item:
File Description SizeFormat 
document_23432_1.pdf63,85 kBAdobe PDFView/Open
document_23432_2.pdf1,26 MBAdobe PDFView/Open

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID